Overview

Tranexamic Acid in Traumatic Brain Injury

Status:
Not yet recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Tranexamic Acid